{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:43:09Z","timestamp":1787002989668,"version":"build-2736575974"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Recent FDA approval for treating Alzheimer\u2019s disease (AD) with amyloid-beta (A\u03b2) immunotherapy is a historic breakthrough, which has rekindled widespread interest in understanding the molecular basis of A\u03b2 toxicity. In this study, we developed a novel\n                    <jats:italic>Drosophila<\/jats:italic>\n                    model to investigate A\u03b242-induced pathologies in vivo and in real time. Strikingly, we unveiled compelling evidence that secreted A\u03b242 affects different neurons in distinct ways\u2014both in susceptibility to A\u03b242 deposition and in the mode of cell death triggered. Additionally, we observed altered larval crawling behaviour which\u2014remarkably\u2014could be recovered by inhibiting ferroptotic cell death with small molecule inhibitors. Collectively these findings showcase this as a powerful new model for investigating A\u03b2 toxicity in AD and identifying novel treatment strategies.\n                  <\/jats:p>","DOI":"10.1038\/s41418-025-01649-7","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:56:46Z","timestamp":1765810606000},"page":"1345-1355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Amyloid-beta induces distinct forms of cell death in different neuronal populations"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6845-1583","authenticated-orcid":false,"given":"Rosalind","family":"Heron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clelia","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1059-5153","authenticated-orcid":false,"given":"Barbara","family":"Monteiro-Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2369-1989","authenticated-orcid":false,"given":"Robert J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5485-0236","authenticated-orcid":false,"given":"Will","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"1649_CR1","doi-asserted-by":"crossref","unstructured":"Cummings JL. Maximizing the benefit and managing the risk of anti-amyloid monoclonal antibody therapy for Alzheimer\u2019s disease: strategies and research directions. Neurotherapeutics. 2025;22:e00570.","DOI":"10.1016\/j.neurot.2025.e00570"},{"key":"1649_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16302","volume":"31","author":"N Villain","year":"2024","unstructured":"Villain N, Michalon R. What is Alzheimer\u2019s disease? An analysis of nosological perspectives from the 20th and 21st centuries. Eur J Neurol. 2024;31:e16302.","journal-title":"Eur J Neurol"},{"key":"1649_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14342","volume":"21","author":"P Aisen","year":"2025","unstructured":"Aisen P, Bateman RJ, Crowther D, Cummings J, Dwyer J, Iwatsubo T, et al. The case for regulatory approval of amyloid-lowering immunotherapies in Alzheimer\u2019s disease based on clearcut biomarker evidence. Alzheimers Dement. 2025;21:e14342.","journal-title":"Alzheimers Dement"},{"key":"1649_CR4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid beta-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther. 2023;8:248.","journal-title":"Signal Transduct Target Ther"},{"key":"1649_CR5","doi-asserted-by":"publisher","first-page":"18295","DOI":"10.1074\/jbc.271.31.18295","volume":"271","author":"DJ Selkoe","year":"1996","unstructured":"Selkoe DJ. Amyloid beta-protein and the genetics of Alzheimer\u2019s disease. J Biol Chem. 1996;271:18295\u20138.","journal-title":"J Biol Chem"},{"key":"1649_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0014-5793(00)02076-7","volume":"483","author":"J Nunan","year":"2000","unstructured":"Nunan J, Small DH. Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett. 2000;483:6\u201310.","journal-title":"FEBS Lett"},{"key":"1649_CR7","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"GF Chen","year":"2017","unstructured":"Chen GF, Xu TH, Yan Y, Zhou YR, Jiang Y, Melcher K, et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharm Sin. 2017;38:1205\u201335.","journal-title":"Acta Pharm Sin"},{"key":"1649_CR8","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/alz.12896","volume":"19","author":"MA Thorwald","year":"2023","unstructured":"Thorwald MA, Silva J, Head E, Finch CE. Amyloid futures in the expanding pathology of brain aging and dementia. Alzheimers Dement. 2023;19:2605\u201317.","journal-title":"Alzheimers Dement"},{"key":"1649_CR9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/325733a0","volume":"325","author":"J Kang","year":"1987","unstructured":"Kang J, Lemaire H-G, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K-H, et al. The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987;325:733\u20136.","journal-title":"Nature"},{"key":"1649_CR10","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1126\/science.8191290","volume":"264","author":"N Suzuki","year":"1994","unstructured":"Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L Jr, Eckman C, et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science. 1994;264:1336\u201340.","journal-title":"Science"},{"key":"1649_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ana.410370303","volume":"37","author":"SG Younkin","year":"1995","unstructured":"Younkin SG. Evidence that A beta 42 is the real culprit in Alzheimer\u2019s disease. Ann Neurol. 1995;37:287\u20138.","journal-title":"Ann Neurol"},{"key":"1649_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","volume":"13","author":"T Iwatsubo","year":"1994","unstructured":"Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron. 1994;13:45\u201353.","journal-title":"Neuron"},{"key":"1649_CR13","doi-asserted-by":"publisher","first-page":"7013","DOI":"10.1074\/jbc.270.13.7013","volume":"270","author":"SA Gravina","year":"1995","unstructured":"Gravina SA, Ho L, Eckman CB, Long KE, Otvos L Jr, Younkin LH, et al. Amyloid beta protein (A beta) in Alzheimer\u2019s disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J Biol Chem. 1995;270:7013\u20136.","journal-title":"J Biol Chem"},{"key":"1649_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0006-8993(98)01143-3","volume":"818","author":"GC Su","year":"1999","unstructured":"Su GC, Arendash GW, Kalaria RN, Bjugstad KB, Mullan M. Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage. Brain Res. 1999;818:105\u201317.","journal-title":"Brain Res"},{"key":"1649_CR15","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","volume":"76","author":"BJ Hanseeuw","year":"2019","unstructured":"Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA, et al. Association of amyloid and tau with cognition in preclinical Alzheimer disease: a longitudinal study. JAMA Neurol. 2019;76:915\u201324.","journal-title":"JAMA Neurol"},{"key":"1649_CR16","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/aps.2015.155","volume":"37","author":"MM Xu","year":"2016","unstructured":"Xu MM, Ren WM, Tang XC, Hu YH, Zhang HY. Advances in development of fluorescent probes for detecting amyloid-beta aggregates. Acta Pharm Sin. 2016;37:719\u201330.","journal-title":"Acta Pharm Sin"},{"key":"1649_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00401-018-1846-7","volume":"136","author":"W Hong","year":"2018","unstructured":"Hong W, Wang Z, Liu W, O\u2019Malley TT, Jin M, Willem M, et al. Diffusible, highly bioactive oligomers represent a critical minority of soluble Abeta in Alzheimer\u2019s disease brain. Acta Neuropathol. 2018;136:19\u201340.","journal-title":"Acta Neuropathol"},{"key":"1649_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.mcn.2004.03.001","volume":"26","author":"A Finelli","year":"2004","unstructured":"Finelli A, Kelkar A, Song HJ, Yang H, Konsolaki M. A model for studying Alzheimer\u2019s Abeta42-induced toxicity in Drosophila melanogaster. Mol Cell Neurosci. 2004;26:365\u201375.","journal-title":"Mol Cell Neurosci"},{"key":"1649_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00401-015-1419-y","volume":"130","author":"S Burnouf","year":"2015","unstructured":"Burnouf S, Gorsky MK, Dols J, Gr\u00f6nke S, Partridge L. A\u03b243 is neurotoxic and primes aggregation of A\u03b240 in vivo. Acta Neuropathol. 2015;130:35\u201347.","journal-title":"Acta Neuropathol"},{"key":"1649_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neurobiolaging.2023.09.008","volume":"132","author":"JH Catterson","year":"2023","unstructured":"Catterson JH, Minkley L, Aspe S, Judd-Mole S, Moura S, Dyson MC, et al. Protein retention in the endoplasmic reticulum rescues Abeta toxicity in Drosophila. Neurobiol Aging. 2023;132:154\u201374.","journal-title":"Neurobiol Aging"},{"key":"1649_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neuroscience.2004.12.025","volume":"132","author":"DC Crowther","year":"2005","unstructured":"Crowther DC, Kinghorn KJ, Miranda E, Page R, Curry JA, Duthie FA, et al. Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer\u2019s disease. Neuroscience. 2005;132:123\u201335.","journal-title":"Neuroscience"},{"key":"1649_CR22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0076-6879(06)12015-7","volume":"412","author":"DC Crowther","year":"2006","unstructured":"Crowther DC, Page R, Chandraratna D, Lomas DA. A Drosophila Model of Alzheimer\u2019s Disease. Methods Enzymol. 2006;412:234\u201355. Academic Press.","journal-title":"Methods Enzymol"},{"key":"1649_CR23","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1016\/j.cub.2016.09.018","volume":"26","author":"T Niccoli","year":"2016","unstructured":"Niccoli T, Cabecinha M, Tillmann A, Kerr F, Wong CT, Cardenes D, et al. Increased Glucose Transport into Neurons Rescues Abeta Toxicity in Drosophila. Curr Biol. 2016;26:2550.","journal-title":"Curr Biol"},{"key":"1649_CR24","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/j.1460-9568.2009.06701.x","volume":"29","author":"T Rival","year":"2009","unstructured":"Rival T, Page RM, Chandraratna DS, Sendall TJ, Ryder E, Liu B, et al. Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer\u2019s disease. Eur J Neurosci. 2009;29:1335\u201347.","journal-title":"Eur J Neurosci"},{"key":"1649_CR25","doi-asserted-by":"publisher","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","volume":"53","author":"The","year":"2025","unstructured":"The, UniProt C. UniProt: the universal protein knowledgebase in 2025. Nucleic Acids Res. 2025;53:D609\u2013D17.","journal-title":"Nucleic Acids Res"},{"key":"1649_CR26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1534\/genetics.110.119917","volume":"186","author":"BD Pfeiffer","year":"2010","unstructured":"Pfeiffer BD, Ngo TT, Hibbard KL, Murphy C, Jenett A, Truman JW, et al. Refinement of tools for targeted gene expression in Drosophila. Genetics. 2010;186:735\u201355.","journal-title":"Genetics"},{"key":"1649_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-2541-5_1","volume":"2540","author":"VK Jenkins","year":"2022","unstructured":"Jenkins VK, Larkin A, Thurmond J, FlyBase C. Using FlyBase: a database of Drosophila genes and genetics. Methods Mol Biol. 2022;2540:1\u201334.","journal-title":"Methods Mol Biol"},{"key":"1649_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1455","volume":"2","author":"A Gomez-Marin","year":"2011","unstructured":"Gomez-Marin A, Stephens GJ, Louis M. Active sampling and decision making in Drosophila chemotaxis. Nat Commun. 2011;2:441.","journal-title":"Nat Commun"},{"key":"1649_CR29","doi-asserted-by":"publisher","first-page":"16085","DOI":"10.1074\/jbc.272.26.16085","volume":"272","author":"C Wild-Bode","year":"1997","unstructured":"Wild-Bode C, Yamazaki T, Capell A, Leimer U, Steiner H, Ihara Y, et al. Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42. J Biol Chem. 1997;272:16085\u20138.","journal-title":"J Biol Chem"},{"key":"1649_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0306-4522(01)00460-2","volume":"110","author":"RG Nagele","year":"2002","unstructured":"Nagele RG, D\u2019Andrea MR, Anderson WJ, Wang HY. Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer\u2019s disease. Neuroscience. 2002;110:199\u2013211.","journal-title":"Neuroscience"},{"key":"1649_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1096\/fj.04-2637fje","volume":"19","author":"Y Ohyagi","year":"2005","unstructured":"Ohyagi Y, Asahara H, Chui DH, Tsuruta Y, Sakae N, Miyoshi K, et al. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer\u2019s disease. FASEB J. 2005;19:255\u20137.","journal-title":"FASEB J"},{"key":"1649_CR32","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.4161\/auto.30001","volume":"10","author":"M Guglielmotto","year":"2014","unstructured":"Guglielmotto M, Monteleone D, Piras A, Valsecchi V, Tropiano M, Ariano S, et al. A\u03b21-42 monomers or oligomers have different effects on autophagy and apoptosis. Autophagy. 2014;10:1827\u201343.","journal-title":"Autophagy"},{"key":"1649_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/imr.13266","volume":"319","author":"R Heron","year":"2023","unstructured":"Heron R, Amato C, Wood W, Davidson AJ. Understanding the diversity and dynamics of in vivo efferocytosis: insights from the fly embryo. Immunol Rev. 2023;319:27\u201344.","journal-title":"Immunol Rev"},{"key":"1649_CR34","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/nprot.2009.143","volume":"4","author":"SE Logue","year":"2009","unstructured":"Logue SE, Elgendy M, Martin SJ. Expression, purification and use of recombinant annexin V for the detection of apoptotic cells. Nat Protoc. 2009;4:1383\u201395.","journal-title":"Nat Protoc"},{"key":"1649_CR35","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1002\/1873-3468.12298","volume":"590","author":"F Pinto-Teixeira","year":"2016","unstructured":"Pinto-Teixeira F, Konstantinides N, Desplan C. Programmed cell death acts at different stages of Drosophila neurodevelopment to shape the central nervous system. FEBS Lett. 2016;590:2435\u201353.","journal-title":"FEBS Lett"},{"key":"1649_CR36","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/s41556-024-01450-7","volume":"26","author":"AJ Davidson","year":"2024","unstructured":"Davidson AJ, Heron R, Das J, Overholtzer M, Wood W. Ferroptosis-like cell death promotes and prolongs inflammation in Drosophila. Nat Cell Biol. 2024;26:1535\u201344.","journal-title":"Nat Cell Biol"},{"key":"1649_CR37","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s13311-020-00954-y","volume":"18","author":"A Gleason","year":"2021","unstructured":"Gleason A, Bush AI. Iron and ferroptosis as therapeutic targets in Alzheimer\u2019s disease. Neurotherapeutics. 2021;18:252\u201364.","journal-title":"Neurotherapeutics"},{"key":"1649_CR38","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/jnc.15519","volume":"159","author":"M Jakaria","year":"2021","unstructured":"Jakaria M, Belaidi AA, Bush AI, Ayton S. Ferroptosis as a mechanism of neurodegeneration in Alzheimer\u2019s disease. J Neurochem. 2021;159:804\u201325.","journal-title":"J Neurochem"},{"key":"1649_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07152-0","volume":"15","author":"N Majernikova","year":"2024","unstructured":"Majernikova N, Marmolejo-Garza A, Salinas CS, Luu MDA, Zhang Y, Trombetta-Lima M, et al. The link between amyloid beta and ferroptosis pathway in Alzheimer\u2019s disease progression. Cell Death Dis. 2024;15:782.","journal-title":"Cell Death Dis"},{"key":"1649_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04927-1","volume":"13","author":"D Wang","year":"2022","unstructured":"Wang D, Tang L, Zhang Y, Ge G, Jiang X, Mo Y, et al. Regulatory pathways and drugs associated with ferroptosis in tumors. Cell Death Dis. 2022;13:544.","journal-title":"Cell Death Dis"},{"key":"1649_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175569","volume":"943","author":"D Li","year":"2023","unstructured":"Li D, Zhang G, Wang Z, Guo J, Liu Y, Lu Y, et al. Idebenone attenuates ferroptosis by inhibiting excessive autophagy via the ROS-AMPK-mTOR pathway to preserve cardiac function after myocardial infarction. Eur J Pharm. 2023;943:175569.","journal-title":"Eur J Pharm"},{"key":"1649_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102708","volume":"62","author":"Y Tian","year":"2023","unstructured":"Tian Y, Xie Y, Guo Z, Feng P, You Y, Yu Q. 17beta-oestradiol inhibits ferroptosis in the hippocampus by upregulating DHODH and further improves memory decline after ovariectomy. Redox Biol. 2023;62:102708.","journal-title":"Redox Biol"},{"key":"1649_CR43","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41420-024-02273-z","volume":"10","author":"G Wang","year":"2024","unstructured":"Wang G, Zhuang W, Zhou Y, Wang X, Li Z, Liu C, et al. 17beta-estradiol alleviated ferroptotic neuroinflammation by suppressing ATF4 in mouse model of Parkinson\u2019s disease. Cell Death Discov. 2024;10:507.","journal-title":"Cell Death Discov"},{"key":"1649_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13024-024-00728-6","volume":"19","author":"A Yehia","year":"2024","unstructured":"Yehia A, Abulseoud OA. Melatonin: a ferroptosis inhibitor with potential therapeutic efficacy for the post-COVID-19 trajectory of accelerated brain aging and neurodegeneration. Mol Neurodegener. 2024;19:36.","journal-title":"Mol Neurodegener"},{"key":"1649_CR45","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"1649_CR46","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao M, Monian P, Quadri N, Ramasamy R, Jiang X. Glutaminolysis and transferrin regulate ferroptosis. Mol Cell. 2015;59:298\u2013308.","journal-title":"Mol Cell"},{"key":"1649_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.15252\/emmm.201505748","volume":"8","author":"HC Chang","year":"2016","unstructured":"Chang HC, Wu R, Shang M, Sato T, Chen C, Shapiro JS, et al. Reduction in mitochondrial iron alleviates cardiac damage during injury. EMBO Mol Med. 2016;8:247\u201367.","journal-title":"EMBO Mol Med"},{"key":"1649_CR48","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","volume":"9","author":"Q Ru","year":"2024","unstructured":"Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F. Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects. Signal Transduct Target Ther. 2024;9:271.","journal-title":"Signal Transduct Target Ther"},{"key":"1649_CR49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/0076-6879(94)34114-1","volume":"234","author":"I Morel","year":"1994","unstructured":"Morel I, Lescoat G, Cillard P, Cillard J. Role of flavonoids and iron chelation in antioxidant action. Methods Enzymol. 1994;234:437\u201343.","journal-title":"Methods Enzymol"},{"key":"1649_CR50","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S0006-2952(98)00102-6","volume":"56","author":"SA van Acker","year":"1998","unstructured":"van Acker SA, van Balen GP, van den Berg DJ, Bast A, van der Vijgh WJ. Influence of iron chelation on the antioxidant activity of flavonoids. Biochem Pharm. 1998;56:935\u201343.","journal-title":"Biochem Pharm"},{"key":"1649_CR51","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12263-009-0143-4","volume":"4","author":"O Weinreb","year":"2009","unstructured":"Weinreb O, Amit T, Mandel S, Youdim MB. Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr. 2009;4:283\u201396.","journal-title":"Genes Nutr"},{"key":"1649_CR52","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.3945\/jn.109.109785","volume":"139","author":"JW Lee","year":"2009","unstructured":"Lee JW, Lee YK, Ban JO, Ha TY, Yun YP, Han SB, et al. Green tea (-)-epigallocatechin-3-gallate inhibits \u03b2-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-\u03baB pathways in mice. J Nutr. 2009;139:1987\u201393.","journal-title":"J Nutr"},{"key":"1649_CR53","doi-asserted-by":"crossref","unstructured":"Valverde-Salazar V, Ruiz-Gabarre D, Garc\u00eda-Escudero V. Alzheimer\u2019s disease and green tea: epigallocatechin-3-gallate as a modulator of inflammation and oxidative stress. Antioxidants. 2023;12:1460.","DOI":"10.3390\/antiox12071460"},{"key":"1649_CR54","doi-asserted-by":"publisher","first-page":"1578S","DOI":"10.1093\/jn\/138.8.1578S","volume":"138","author":"SA Mandel","year":"2008","unstructured":"Mandel SA, Amit T, Kalfon L, Reznichenko L, Youdim M. Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. J Nutr. 2008;138:1578S\u201383S.","journal-title":"J Nutr"},{"key":"1649_CR55","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA. 1985;82:4245\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1649_CR56","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1111\/j.1471-4159.1986.tb08501.x","volume":"46","author":"DJ Selkoe","year":"1986","unstructured":"Selkoe DJ, Abraham CR, Podlisny MB, Duffy LK. Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer\u2019s disease. J Neurochem. 1986;46:1820\u201334.","journal-title":"J Neurochem"},{"key":"1649_CR57","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(94)92338-8","volume":"344","author":"MJ West","year":"1994","unstructured":"West MJ, Coleman PD, Flood DG, Troncoso JC. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer\u2019s disease. Lancet. 1994;344:769\u201372.","journal-title":"Lancet"},{"key":"1649_CR58","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Serra R, Alonso-Nanclares L, Cho K, Giese KP. Emerging insights into synapse dysregulation in Alzheimer\u2019s disease. Brain Commun. 2022;4:fcac083.","DOI":"10.1093\/braincomms\/fcac083"},{"key":"1649_CR59","first-page":"282","volume":"5","author":"M Morishima","year":"1994","unstructured":"Morishima M, Ihara Y. Posttranslational modifications of tau in paired helical filaments. Dementia. 1994;5:282\u20138.","journal-title":"Dementia"},{"key":"1649_CR60","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ. Alzheimer\u2019s disease is a synaptic failure. Science. 2002;298:789\u201391.","journal-title":"Science"},{"key":"1649_CR61","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","volume":"192","author":"DJ Selkoe","year":"2008","unstructured":"Selkoe DJ. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res. 2008;192:106\u201313.","journal-title":"Behav Brain Res"},{"key":"1649_CR62","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 1996;274:99\u2013102.","journal-title":"Science"},{"key":"1649_CR63","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1523\/JNEUROSCI.22-05-01858.2002","volume":"22","author":"MA Westerman","year":"2002","unstructured":"Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, et al. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer\u2019s disease. J Neurosci. 2002;22:1858\u201367.","journal-title":"J Neurosci"},{"key":"1649_CR64","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1097\/00001756-199710200-00006","volume":"8","author":"WK Cullen","year":"1997","unstructured":"Cullen WK, Suh YH, Anwyl R, Rowan MJ. Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments. Neuroreport. 1997;8:3213\u20137.","journal-title":"Neuroreport"},{"key":"1649_CR65","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.1523\/JNEUROSCI.21-15-05703.2001","volume":"21","author":"A Stephan","year":"2001","unstructured":"Stephan A, Laroche S, Davis S. Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci. 2001;21:5703\u201314.","journal-title":"J Neurosci"},{"key":"1649_CR66","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med. 2008;14:837\u201342.","journal-title":"Nat Med"},{"key":"1649_CR67","doi-asserted-by":"publisher","first-page":"a006338","DOI":"10.1101\/cshperspect.a006338","volume":"2","author":"L Mucke","year":"2012","unstructured":"Mucke L, Selkoe DJ. Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med. 2012;2:a006338.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1649_CR68","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1096\/fj.01-0377com","volume":"15","author":"H Lin","year":"2001","unstructured":"Lin H, Bhatia R, Lal R. Amyloid \u03b2 protein forms ion channels: implications for Alzheimer\u2019s disease pathophysiology. FASEB J. 2001;15:2433\u201344.","journal-title":"FASEB J"},{"key":"1649_CR69","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS. Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014;71:505\u20138.","journal-title":"JAMA Neurol"},{"key":"1649_CR70","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486\u2013541.","journal-title":"Cell Death Differ"},{"key":"1649_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.937133","volume":"15","author":"P Goel","year":"2022","unstructured":"Goel P, Chakrabarti S, Goel K, Bhutani K, Chopra T, Bali S. Neuronal cell death mechanisms in Alzheimer\u2019s disease: an insight. Front Mol Neurosci. 2022;15:937133.","journal-title":"Front Mol Neurosci"},{"key":"1649_CR72","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00401-024-02722-0","volume":"147","author":"DR Thal","year":"2024","unstructured":"Thal DR, Gawor K, Moonen S. Regulated cell death and its role in Alzheimer\u2019s disease and amyotrophic lateral sclerosis. Acta Neuropathol. 2024;147:69.","journal-title":"Acta Neuropathol"},{"key":"1649_CR73","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/j.neuron.2025.04.017","volume":"113","author":"YJ Park","year":"2025","unstructured":"Park YJ, Lu TC, Jackson T, Goodman LD, Ran L, Chen J, et al. Distinct systemic impacts of Abeta42 and Tau revealed by whole-organism snRNA-seq. Neuron. 2025;113:2065\u201382 e8.","journal-title":"Neuron"},{"key":"1649_CR74","first-page":"373","volume":"7","author":"SD Mhatre","year":"2014","unstructured":"Mhatre SD, Satyasi V, Killen M, Paddock BE, Moir RD, Saunders AJ, et al. Synaptic abnormalities in a model of Alzheimer\u2019s disease. Dis Model Mech. 2014;7:373\u201385.","journal-title":"Dis Model Mech"},{"key":"1649_CR75","doi-asserted-by":"publisher","DOI":"10.14440\/jbm.2016.61","volume":"3","author":"X Wang","year":"2016","unstructured":"Wang X, Zhao Y, Hu Y, Ren P, Sun Y, Guo X, et al. Establishment of a Drosophila AD model. J Biol Methods. 2016;3:e43.","journal-title":"J Biol Methods"},{"key":"1649_CR76","doi-asserted-by":"crossref","unstructured":"G\u00fcnther MN, Nettesheim G, Shubeita GT. Quantifying and predicting larvae crawling phenotypes. Sci Rep. 2016;6:27972.","DOI":"10.1038\/srep27972"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01649-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01649-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01649-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:04:32Z","timestamp":1783433072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01649-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1649"],"URL":"https:\/\/doi.org\/10.1038\/s41418-025-01649-7","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}